58,000例介入性疼痛操作中的出血与神经系统并发症
该回顾性队列研究纳入2005至2014年间单中心接受低、中风险疼痛操作的58,066例次操作,评估出血并发症发生率,重点关注抗血小板/抗凝药物使用及凝血异常。结果显示围术期红细胞输注率0.03%,神经系统并发症需进一步评估者0.009%(5例),其中2例可能与操作出血相关;术前使用非甾体抗炎药(包括阿司匹林)或其他抗凝药物与输血风险无差异(P=0.107)。结论认为低、中风险疼痛操作出血并发症罕见,即使在使用抗血小板药物的情况下亦然,与近期指南一致。
要点
- 低、中风险疼痛操作出血并发症罕见,输血率仅0.03%。
- 术前使用阿司匹林/非甾体抗炎药或其他抗凝药不增加输血风险(P=0.107)。
- 神经系统并发症需进一步评估者仅0.009%,其中2例可能与操作出血相关。
核心结论
- 低、中风险疼痛操作出血并发症罕见,即使存在抗血小板药物使用。
- 结果与近期发布的指南一致。
研究设计与样本
- 单中心学术三级医疗中心疼痛医学科的回顾性队列研究。
- 纳入2005年至2014年接受低、中风险疼痛操作的成年患者,共58,066例次操作,涉及24,590例独特患者。
主要发现
- 17,825例次操作(30.7%)术前使用阿司匹林或非甾体抗炎药。
- 5例患者(0.009%)出现需进一步评估的神经系统并发症,其中2例可能与操作出血相关。
临床怎么用
- 低、中风险疼痛操作前使用抗血小板药物(包括阿司匹林)或非甾体抗炎药时,出血并发症风险低,可参考近期指南进行管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Interventional pain procedures are commonly performed on patients receiving antiplatelet therapy. However, there is limited evidence to support or refute the safety of this practice. The goal of this investigation was to assess the rate of bleeding complications in a large cohort of patients undergoing intermediate- and low-risk pain procedures, with a specific focus on antiplatelet and anticoagulant medication use and baseline coagulation abnormalities. METHODS: This is a retrospective cohort study of adult patients undergoing low- and intermediate-risk pain procedures from 2005 through 2014 by the division of pain medicine at a single academic tertiary care center. Baseline characteristics, antiplatelet and anticoagulant medication use, coagulation parameters, and procedural details were extracted from the electronic medical record. The primary outcome was a bleeding-related complication requiring emergency medicine, neurology, or neurosurgical evaluation within 31 days. The secondary outcome was the presence or absence of a periprocedural red blood cell transfusion occurring within 72 hours of needle placement. RESULTS: A total of 58,066 procedures were performed on 24,590 unique patients. Preprocedural aspirin or nonsteroidal anti-inflammatory drug therapy was present for 17,825 procedures (30.7%). Sixteen procedures were associated with perioperative red blood cell transfusion (0.03%), with no difference based on preprocedural nonsteroidal anti-inflammatory drug, including aspirin, or other anticoagulation use (P = 0.107). Five patients (0.009%) had a neurologic complication requiring further evaluation, of which 2 were likely related to procedural bleeding. CONCLUSIONS: Bleeding complications are rare in patients undergoing low- or intermediate-risk pain procedures even in the presence of antiplatelet medications. This is consistent with recently released guidelines.
引用
- Warner NS, Hooten WM, Warner MA, et al. Bleeding and Neurologic Complications in 58,000 Interventional Pain Procedures. Reg Anesth Pain Med. 2017. PMID: 29016553. doi:10.1097/AAP.0000000000000672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。